Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Diana Alpenidze"'
Autor:
Sevastyan Rabdano, Ellina Ruzanova, Denis Makarov, Anastasiya Vertyachikh, Valeriya Teplykh, German Rudakov, Iuliia Pletyukhina, Nikita Saveliev, Konstantin Zakharov, Diana Alpenidze, Vasiliy Vasilyuk, Sergei Arakelov, Veronika Skvortsova
Publikováno v:
Vaccines, Vol 12, Iss 1, p 100 (2024)
We have developed Convacell®—a COVID-19 vaccine based on the recombinant nucleocapsid (N) protein of SARS-CoV-2. This paper details Convacell’s® combined phase I/II and IIb randomized, double-blind, interventional clinical trials. The primary e
Externí odkaz:
https://doaj.org/article/7e89e272619449aabe4f57f79c0528b5
Autor:
Olga Smirnova, Olga Ershova, Marina Shestakova, Boris Kvasnikov, Ekaterina Erina, Elena Isachenko, Alexander Andreev, Diana Alpenidze, Alexander Ametov, Olga Demicheva, Irina Dvoryashina, Polina Ermakova, Elena Grineva, Yuriy Khalimov, Ludmila Kvitkova, Anatoliy Kuzin, Olga Lantseva, Nina Leonova, Tatiana Lysenko, Tatiana Markova, Ashot Mkrtumyan, Nina Nosova, Natalia Osokina, Leonid Pimenov, Larisa Rogova, Ludmila Ruyatkina, Oksana Rymar, Olesya Shabelnikova, Elena Smirnova, Alexander Sobolev, Leonid Strongin, Ludmila Suplotova, Andrey Verbovoy, Anna Volkova, Alsu Zalevskaya, Olga Zanozina, Elena Zhdanova, Larisa Zhukova
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 11, Iss 3 (2023)
Introduction Most data demonstrating the efficacy and safety of luseogliflozin (luseo) in people with type 2 diabetes mellitus (T2DM) originate from the Japanese population. This study evaluated luseo versus placebo (PCB) as add-on to metformin in a
Externí odkaz:
https://doaj.org/article/34787bdfe2504b84a7a0adcbeddd008d
Autor:
Stephen A. Harrison, Federico Perez Manghi, William B. Smith, Diana Alpenidze, Diego Aizenberg, Naomi Klarenbeek, Chi-Yi Chen, Eli Zuckerman, Eric Ravussin, Phunchai Charatcharoenwitthaya, Pin-Nan Cheng, Helena Katchman, Samuel Klein, Ziv Ben-Ari, Anisha E. Mendonza, Yiming Zhang, Miljen Martic, Shenglin Ma, Sheena Kao, Sandra Tanner, Alok Pachori, Michael K. Badman, YanLing He, Chinweike Ukomadu, Eric Sicard
Publikováno v:
Nat Med
Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease that may advance to fibrosis and lead to mortality; however, no pharmacotherapy is currently available. We tested the hypothesis that inhibition of both the sodium-glucose cotransp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e75d88194984d7468a9e9fe7ccab93e
https://europepmc.org/articles/PMC10061496/
https://europepmc.org/articles/PMC10061496/
